Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT)
出版年份 2021 全文链接
标题
Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT)
作者
关键词
-
出版物
Cancers
Volume 13, Issue 12, Pages 2904
出版商
MDPI AG
发表日期
2021-06-11
DOI
10.3390/cancers13122904
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Chromaffin Cells with Sympathoblast Signature: Too Similar to Keep Apart?
- (2021) Oscar C. Bedoya-Reina et al. CANCER CELL
- Response to Kildsiute et al. and Bedoya-Reina and Schlisio
- (2021) Ran Yang et al. CANCER CELL
- Pitfalls of Applying Mouse Markers to Human Adrenal Medullary Cells
- (2021) Gerda Kildisiute et al. CANCER CELL
- Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell
- (2021) Gerda Kildisiute et al. Science Advances
- Evolutionary switch in expression of key markers between mouse and human leads to mis-assignment of cell types in developing adrenal medulla
- (2021) Polina Kameneva et al. CANCER CELL
- Linking human sympathoadrenal development and neuroblastoma
- (2021) Hermann Rohrer NATURE GENETICS
- Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin
- (2021) Polina Kameneva et al. NATURE GENETICS
- Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma
- (2021) Selina Jansky et al. NATURE GENETICS
- Large 1p36 Deletions Affecting Arid1a Locus Facilitate Mycn-Driven Oncogenesis in Neuroblastoma
- (2020) Jesus García-López et al. Cell Reports
- EMT, MET, Plasticity, and Tumor Metastasis
- (2020) Basil Bakir et al. TRENDS IN CELL BIOLOGY
- ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression
- (2020) Hui Shi et al. Science Advances
- Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma
- (2020) Rui Dong et al. CANCER CELL
- Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
- (2019) John Inge Johnsen et al. Frontiers in Molecular Neuroscience
- Catecholamine excretion profiles identify clinical subgroups of neuroblastoma patients
- (2019) I.R.N. Verly et al. EUROPEAN JOURNAL OF CANCER
- A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma
- (2019) Tim van Groningen et al. Nature Communications
- Cancer Stem Cells and Neuroblastoma: Characteristics and Therapeutic Targeting Options
- (2019) Veronica Veschi et al. Frontiers in Endocrinology
- ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry
- (2019) Lu Wang et al. Nature Communications
- Spontaneous regression of neuroblastoma
- (2018) Garrett M. Brodeur CELL AND TISSUE RESEARCH
- Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma
- (2018) Rhamy Zeid et al. NATURE GENETICS
- Cross-Cohort Analysis Identifies a TEAD4–MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma
- (2018) Presha Rajbhandari et al. Cancer Discovery
- Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry
- (2018) Adam D. Durbin et al. NATURE GENETICS
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
- (2018) Bieke Decaesteker et al. Nature Communications
- Neuroblastoma is composed of two super-enhancer-associated differentiation states
- (2017) Tim van Groningen et al. NATURE GENETICS
- Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
- (2017) Valentina Boeva et al. NATURE GENETICS
- Neuroblastoma
- (2016) Katherine K. Matthay et al. Nature Reviews Disease Primers
- The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro
- (2015) Olga Piskareva et al. CANCER LETTERS
- ALK inhibitor resistance in ALKF1174L-driven neuroblastoma is associated with AXL activation and induction of EMT
- (2015) D N Debruyne et al. ONCOGENE
- CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
- (2014) Edmond Chipumuro et al. CELL
- Clinical, Biologic, and Prognostic Differences on the Basis of Primary Tumor Site in Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project
- (2014) Kieuhoa T. Vo et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncogenic roles of EMT-inducing transcription factors
- (2014) Alain Puisieux et al. NATURE CELL BIOLOGY
- Super-Enhancers in the Control of Cell Identity and Disease
- (2013) Denes Hnisz et al. CELL
- Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours
- (2013) Laurel T. Bate-Eya et al. EUROPEAN JOURNAL OF CANCER
- Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
- (2013) Alexandre Puissant et al. Cancer Discovery
- Metastatic Colonization Requires the Repression of the Epithelial-Mesenchymal Transition Inducer Prrx1
- (2012) Oscar H. Ocaña et al. CANCER CELL
- Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
- (2012) Mark Sausen et al. NATURE GENETICS
- Transcriptional control of differentiation and neurogenesis in autonomic ganglia
- (2011) Hermann Rohrer EUROPEAN JOURNAL OF NEUROSCIENCE
- Molecular pathogenesis of peripheral neuroblastic tumors
- (2010) I Janoueix-Lerosey et al. ONCOGENE
- Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
- (2009) T. Arumugam et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started